SR
CME icon

Syntax Research’s CME Group CME Stock Holding History

Syntax Research’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$787K Buy
+3,564
New +$986K 0.58% 31
2025
Q2 		– Sell
-1,857
Closed -$493K – 173
2025
Q1 		$493K Sell
1,857
-147
-7% -$36.3K 0.34% 52
2024
Q4 		$465K Sell
2,004
-9,509
-83% -$2.19M 0.33% 47
2024
Q3 		$2.54M Buy
+11,513
New +$2.38M 1.72% 25

Other funds holding CME

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Syntax Research's CME Position: Q2 2026 in Review

Syntax Research opened a new position in CME Group (CME) in Q2 2026: 3,564 shares worth $787K. The stake represents 0.58% of the portfolio and ranks #31 among its holdings. This is a return to the name: Syntax Research previously reported a position in CME as recently as Q1 2025.

Syntax Research first reported a position in CME in Q3 2024 and has held it in 4 quarters since. The position peaked at $2.54M in Q3 2024. 1,703 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Syntax Research held 3,564 shares of CME Group worth $787K as of Q2 2026.
  • CME Group was a new Syntax Research position in Q2 2026.
  • CME Group made up 0.58% of Syntax Research's portfolio in Q2 2026, its #31 holding.
  • Syntax Research first reported a position in CME Group in Q3 2024 and has held it in 4 quarters since.
  • Syntax Research's CME Group position peaked at $2.54M in Q3 2024.
  • 1,703 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Syntax Research's 13F filing for Q2 2026, filed 31 Jul 2026.